Circ_0109046 Promotes the Malignancy of Endometrial Carcinoma Cells Through the MicroRNA-105/SOX9/Wnt/β-catenin Axis
Overview
Molecular Biology
Authors
Affiliations
Emerging evidence suggests the important involvements of circular RNAs (circRNAs) in cancer progression. This study focuses on the function of Circ_0109046 on the malignancy of endometrial carcinoma (EC) cells and the molecules involved. First, high expression of Circ_0109046 was found in EC tissues compared to the adjacent tissues, and it predicted unfavorable prognosis in patients. Similarly, high expression of Circ_0109046 was confirmed in EC cells relative to that in normal endometrial epithelial cells. Silencing of Circ_0109046 in AN3-CA cells inhibited proliferation and aggressiveness but increased apoptosis of cells. Circ_0109046 was mainly sub-localized in cytoplasm, and it mediated SOX9 expression through sponging microRNA (miR)-105. The proliferation and aggressiveness of EC cells suppressed by Circ_0109046 downregulation was recovered upon SOX9 overexpression. SOX9 activated the Wnt/β-catenin pathway. Furthermore, downregulation of Circ_0109046 reduced the growth of xenograft tumors in nude mice. This study evidenced that Circ_0109046 upregulates SOX9 expression through sponging miR105, leading to activation of Wnt/β-catenin signaling and the malignant growth of EC. This study may offer novel understanding in EC treatment.
Shahpari M, Hashemi M, Younesirad T, Hasanzadeh A, Mosanne M, Ahmadifard M Heliyon. 2024; 10(21):e37089.
PMID: 39524849 PMC: 11546195. DOI: 10.1016/j.heliyon.2024.e37089.
circRNAs in Endometrial Cancer-A Promising Biomarker: State of the Art.
Wlodarczyk K, Kurylo W, Pawlowska-Lachut A, Skiba W, Suszczyk D, Pieniadz P Int J Mol Sci. 2024; 25(12).
PMID: 38928094 PMC: 11203539. DOI: 10.3390/ijms25126387.
What is the role of circRNAs in the pathogenesis of cervical cancer? A systematic literature review.
Matos A, Silva G, Barbosa E, de Andrade M, Lages J, Correa R Front Genet. 2024; 15:1287869.
PMID: 38859935 PMC: 11163134. DOI: 10.3389/fgene.2024.1287869.
Zheng L, Chen S, Zhou L, Huang Q, Chen J, Chen W Front Oncol. 2023; 13:1277543.
PMID: 38074657 PMC: 10703048. DOI: 10.3389/fonc.2023.1277543.
Nitta Y, Fujii T, Uchiyama T, Sugimoto A, Nishikawa T, Takeda M Biomedicines. 2023; 11(11).
PMID: 38002064 PMC: 10669193. DOI: 10.3390/biomedicines11113064.